See more : Americold Realty Trust, Inc. (COLD) Income Statement Analysis – Financial Results
Complete financial analysis of LifePoint, Inc. (LFPI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LifePoint, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Mrs. Bectors Food Specialities Limited (BECTORFOOD.NS) Income Statement Analysis – Financial Results
- Continental Holdings Limited (0513.HK) Income Statement Analysis – Financial Results
- Dong Il Steel Mfg Co.,Ltd (002690.KS) Income Statement Analysis – Financial Results
- DINE, S.A.B. de C.V. (DINEA.MX) Income Statement Analysis – Financial Results
- Curative Biotechnology, Inc. (CUBT) Income Statement Analysis – Financial Results
LifePoint, Inc. (LFPI)
About LifePoint, Inc.
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.
| Metric | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|
| Revenue | -18.50K | 48.71K | 135.98K | 1.00 | 1.00 | 1.00 |
| Cost of Revenue | 52.86K | 1.32M | 623.24K | 0.00 | 0.00 | 0.00 |
| Gross Profit | -71.36K | -1.27M | -487.26K | 1.00 | 1.00 | 1.00 |
| Gross Profit Ratio | 385.72% | -2,603.98% | -358.33% | 100.00% | 100.00% | 100.00% |
| Research & Development | 4.16M | 9.79M | 7.41M | 5.18M | 2.45M | 1.12M |
| General & Administrative | 2.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 671.43K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.27M | 4.63M | 4.36M | 2.15M | 1.52M | 1.48M |
| Other Expenses | -7.46M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 7.42M | 14.42M | 12.30M | 7.59M | 4.07M | 2.74M |
| Cost & Expenses | 7.48M | 15.73M | 12.92M | 7.59M | 4.07M | 2.74M |
| Interest Income | 23.45K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 304.37K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 725.09K | 839.10K | 521.50K | 255.44K | 99.69K | 142.39K |
| EBITDA | -14.20M | -14.85M | -12.26M | -7.33M | -3.97M | -2.60M |
| EBITDA Ratio | 76,768.31% | -30,478.78% | -9,017.76% | -733,221,500.00% | -396,625,900.00% | -260,092,000.00% |
| Operating Income | -7.50M | -15.69M | -12.78M | -7.59M | -4.07M | -2.74M |
| Operating Income Ratio | 40,514.75% | -32,201.31% | -9,401.27% | -758,765,000.00% | -406,595,200.00% | -274,330,700.00% |
| Total Other Income/Expenses | -7.74M | -7.74M | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -15.23M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Before Tax Ratio | 82,332.96% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -7.15M | 380.96K | -186.88K | -425.12K | -116.17K | -46.59K |
| Net Income | -15.23M | -16.07M | -12.60M | -7.16M | -3.95M | -2.70M |
| Net Income Ratio | 82,332.96% | -32,983.37% | -9,263.84% | -716,252,900.00% | -394,978,400.00% | -269,671,300.00% |
| EPS | -0.36 | -0.45 | -0.40 | -0.23 | -0.26 | -0.23 |
| EPS Diluted | -0.36 | -0.45 | -0.40 | -0.23 | -0.26 | -0.23 |
| Weighted Avg Shares Out | 42.30M | 35.83M | 31.75M | 30.49M | 15.25M | 11.57M |
| Weighted Avg Shares Out (Dil) | 42.30M | 35.83M | 31.75M | 30.49M | 15.25M | 11.57M |
Source: https://incomestatements.info
Category: Stock Reports